Literature DB >> 24008493

The impact of surgical technique on the results of liver transplantation in patients with hepatocellular carcinoma.

Michał Grąt1, Oskar Kornasiewicz, Zbigniew Lewandowski, Michał Skalski, Krzysztof Zieniewicz, Leszek Pączek, Marek Krawczyk.   

Abstract

BACKGROUND: Although piggyback technique has gained widespread acceptance for liver transplantation in general, there is an exceptional lack of data on the choice of appropriate surgical technique for patients with hepatocellular carcinoma (HCC). The purpose of this study was to evaluate the impact of surgical technique on outcomes after liver transplantation for HCC.
MATERIAL AND METHODS: We conducted a retrospective cohort study on 90 HCC patients who underwent liver transplantation with the conventional (n=19) or piggyback (n=71) technique. Both techniques were compared with respect to intraoperative variables and long-term outcomes, determined by 3-year overall (OS) and recurrence-free (RFS) survival. The potential role of confounding factors was excluded in a series of Cox proportional regression models.
RESULTS: The piggyback technique was associated with shorter procedure duration (p=0.0005), shorter anatomical anhepatic phase (p<0.0001), shorter duration of total (p=0.018) and warm ischemia (p<0.0001), and fewer blood transfusions (p=0.006). Three-year OS was 89.1% after piggyback and 49.9% after conventional transplantation (p=0.0008), with 3-year RFS of 89.4% and 56.0% (p=0.0006), respectively. Piggyback transplantations provided outcomes superior to conventional procedures both in patients within (p=0.019 for OS; p=0.003 for RFS) and beyond (p=0.023 for OS; p=0.031 for RFS) Milan criteria. Multivariate analysis of the risks of death and recurrence confirmed the benefits of piggyback technique.
CONCLUSIONS: Given its superior long-term outcome, piggyback transplantation might be considered primarily for HCC patients.

Entities:  

Mesh:

Year:  2013        PMID: 24008493     DOI: 10.12659/AOT.884005

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  11 in total

1.  Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.

Authors:  Michał Grąt; Oskar Kornasiewicz; Zbigniew Lewandowski; Wacław Hołówko; Karolina Grąt; Konrad Kobryń; Waldemar Patkowski; Krzysztof Zieniewicz; Marek Krawczyk
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

Review 2.  Obtaining Optimal Long-Term Outcomes from Liver Transplantation for Hepatocellular Cancer.

Authors:  Trevor W Reichman; Chandra S Bhati; Narendra R Battula
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

Review 3.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

4.  Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer.

Authors:  Michał Grąt; Jan Stypułkowski; Waldemar Patkowski; Karolina M Wronka; Emil Bik; Maciej Krasnodębski; Łukasz Masior; Zbigniew Lewandowski; Michał Wasilewicz; Karolina Grąt; Marek Krawczyk; Krzysztof Zieniewicz
Journal:  Ann Surg Oncol       Date:  2017-07-10       Impact factor: 5.344

5.  Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation.

Authors:  Michał Grąt; Jan Stypułkowski; Waldemar Patkowski; Emil Bik; Maciej Krasnodębski; Karolina M Wronka; Zbigniew Lewandowski; Michał Wasilewicz; Karolina Grąt; Łukasz Masior; Joanna Ligocka; Marek Krawczyk
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

6.  Applicability of common inflammatory markers in diagnosing infections in early period after liver transplantation in intensive care setting.

Authors:  Wojciech Figiel; Michał Grąt; Grzegorz Niewiński; Waldemar Patkowski; Krzysztof Zieniewicz
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

7.  Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation.

Authors:  Karolina Grąt; Ryszard Pacho; Michał Grąt; Marek Krawczyk; Krzysztof Zieniewicz; Olgierd Rowiński
Journal:  J Clin Med       Date:  2019-10-13       Impact factor: 4.241

8.  Importance of Intraoperative Transfusions of Packed Red Blood Cells and Fresh Frozen Plasma in Liver Transplantation for Hepatocellular Cancer.

Authors:  Łukasz Masior; Michał Grąt; Karolina Grąt; Maciej Krasnodębski; Karolina M Wronka; Jan Stypułkowski; Waldemar Patkowski; Mariusz Frączek; Marek Krawczyk; Krzysztof Zieniewicz
Journal:  Ann Transplant       Date:  2020-10-09       Impact factor: 1.530

9.  Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation.

Authors:  Michał Grąt; Marek Krawczyk; Karolina M Wronka; Jan Stypułkowski; Zbigniew Lewandowski; Michał Wasilewicz; Piotr Krawczyk; Karolina Grąt; Waldemar Patkowski; Krzysztof Zieniewicz
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

10.  Prognostic Relevance of a Complete Pathologic Response in Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Michał Grąt; Marek Krawczyk; Jan Stypułkowski; Marcin Morawski; Maciej Krasnodębski; Michał Wasilewicz; Zbigniew Lewandowski; Karolina Grąt; Waldemar Patkowski; Krzysztof Zieniewicz
Journal:  Ann Surg Oncol       Date:  2019-09-13       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.